Estradiol | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Estradiol
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Estradiol

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Estradiol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

71 API Suppliers, 11 USDMF, 12 CEP/COS, 2 JDMF, 11 EU WC, 10 KDMF, 37 NDC API, 3 VMF, 18 Listed Suppliers, $ API Reference Price

71 API Suppliers
11 USDMF
12 CEP/COS
2 JDMF
11 EU WC
10 KDMF
37 NDC API
3 VMF
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

148 Drugs in Development

148 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

547 FDF Dossiers, 229 FDA Orange Book, 221 Europe, 29 Canada, 30 Australia, 27 South Africa, 11 Listed Dossiers

547 FDF Dossiers
229 FDA Orange Book
221 Europe
29 Canada
30 Australia
27 South Africa
11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.025MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.0375MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.06MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.075MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.1MG/24HR, INSERT, EXTENDED RELEASE;VAGINAL - 0.0075MG/24HR, SYSTEM;TRANSDERMAL - 0.025MG/24HR, SYSTEM;TRANSDERMAL - 0.0375MG/24HR, SYSTEM;TRANSDERMAL - 0.05MG/24HR, SYSTEM;TRANSDERMAL - 0.075MG/24HR, SYSTEM;TRANSDERMAL - 0.1MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR, TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG;0.5MG, TABLET;VAGINAL - 10MCG, TABLET;VAGINAL - 25MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 0.5MG;100MG, CAPSULE;ORAL - 1MG;100MG, GEL, METERED;TRANSDERMAL - 0.06% (1.25GM/ACTIVATION), FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR, TABLET;ORAL - 0.25MG;0.5MG, TABLET;ORAL - 0.5MG;1MG, GEL, METERED;TRANSDERMAL - 0.06% (0.87GM/ACTIVATION), SPRAY;TRANSDERMAL - 1.53MG/SPRAY, GEL;TRANSDERMAL - 0.1% (0.25GM/PACKET), GEL;TRANSDERMAL - 0.1% (0.5GM/PACKET), GEL;TRANSDERMAL - 0.1% (0.75GM/PACKET), GEL;TRANSDERMAL - 0.1% (1.25GM/PACKET), GEL;TRANSDERMAL - 0.1% (1GM/PACKET), CREAM;VAGINAL - 0.01%

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.025MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.0375MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.06MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.075MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.1MG/24HR
INSERT, EXTENDED RELEASE;VAGINAL - 0.0075MG/24HR
SYSTEM;TRANSDERMAL - 0.025MG/24HR
SYSTEM;TRANSDERMAL - 0.0375MG/24HR
SYSTEM;TRANSDERMAL - 0.05MG/24HR
SYSTEM;TRANSDERMAL - 0.075MG/24HR
SYSTEM;TRANSDERMAL - 0.1MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR
TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1MG;0.5MG
TABLET;VAGINAL - 10MCG
TABLET;VAGINAL - 25MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 0.5MG;100MG
CAPSULE;ORAL - 1MG;100MG
GEL, METERED;TRANSDERMAL - 0.06% (1.25GM/ACTIVATION)
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR
TABLET;ORAL - 0.25MG;0.5MG
TABLET;ORAL - 0.5MG;1MG
GEL, METERED;TRANSDERMAL - 0.06% (0.87GM/ACTIVATION)
SPRAY;TRANSDERMAL - 1.53MG/SPRAY
GEL;TRANSDERMAL - 0.1% (0.25GM/PACKET)
GEL;TRANSDERMAL - 0.1% (0.5GM/PACKET)
GEL;TRANSDERMAL - 0.1% (0.75GM/PACKET)
GEL;TRANSDERMAL - 0.1% (1.25GM/PACKET)
GEL;TRANSDERMAL - 0.1% (1GM/PACKET)
CREAM;VAGINAL - 0.01%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 8 SPI Pharma, 12 DKSH, 6 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 9 Kirsch Pharma, 4 ACG Worldwide, 8 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 33 BASF, 1 BioSpectra, 2 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 16 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 20 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 55 Coating Systems & Additives, 40 Direct Compression, 38 Thickeners and Stabilizers, 36 Granulation, 35 Solubilizers, 34 Topical, 31 Disintegrants & Superdisintegrants, 30 Controlled & Modified Release, 27 Parenteral, 22 Film Formers & Plasticizers, 21 Lubricants & Glidants, 18 Taste Masking, 17 Emulsifying Agents, 14 Co-Processed Excipients, 10 Chewable & Orodispersible Aids, 9 Empty Capsules, 9 API Stability Enhancers, 8 Surfactant & Foaming Agents, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules

73 Fillers, Diluents & Binders
55 Coating Systems & Additives
40 Direct Compression
38 Thickeners and Stabilizers
36 Granulation
35 Solubilizers
34 Topical
31 Disintegrants & Superdisintegrants
30 Controlled & Modified Release
27 Parenteral
22 Film Formers & Plasticizers
21 Lubricants & Glidants
18 Taste Masking
17 Emulsifying Agents
14 Co-Processed Excipients
10 Chewable & Orodispersible Aids
9 Empty Capsules
9 API Stability Enhancers
8 Surfactant & Foaming Agents
7 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 43 News #PharmaBuzz

2 Data Compilation #PharmaFlow
43 News #PharmaBuzz

GLOBAL SALES INFORMATION

42 US Medicaid Prescriptions, 125 Regulatory FDF Prices, 8 Annual Reports

42 US Medicaid Prescriptions
125 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

13 APIs, 3 FDF Dossiers

13 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

129 US Patents, 4 US Exclusivities, 5 Health Canada Patents

129 US Patents
4 US Exclusivities
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 16 Others

4 EDQM
2 USP
16 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,807 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 1Intervet Canada Corp.

02 4Knight Therapeutics Inc

filter Patent Reset all filters

5 All

01 12348841

02 22856520

03 22876968

filter Product Reset all filters

5 All

01 2ESTRADIOL HEMIHYDRATE

02 2ESTRADIOL HEMIHYDRATE | PROGESTERONE

03 1TRENBOLONE ACETATE | ESTRADIOL

filter Dosage Reset all filters

5 All

01 2CAPSULE

02 1IMPLANT

03 2INSERT

filter Exp Date Reset all filters

5 All

01 12019-11-02

02 22032-11-21

03 22033-06-18

Symbiotec Estradiol

Product Main Page

01

Intervet Canada Corp.

TRENBOLONE ACETATE, ESTRADIOL

ChemOutsourcing

Not Confirmed

Intervet Canada Corp.

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-11-02

Date Granted : 2007-04-17

TRENBOLONE ACETATE, ESTRADIOL

Brand Name : REVALOR XH

Patent Number : 2348841

Filing Date : 1999-11-02

Strength per Unit : 200 mg / 20 mg

Dosage Form : IMPLANT

Human Or VET : Veterinary

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2019-11-02

Date Granted : 2007-04-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Knight Therapeutics Inc

ESTRADIOL HEMIHYDRATE, PROGESTERONE

ChemOutsourcing

Not Confirmed

Knight Therapeutics Inc

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-21

Date Granted : 2021-04-06

ESTRADIOL HEMIHYDRATE, PROGESTERONE

Brand Name : BIJUVA

Patent Number : 2856520

Filing Date : 2012-11-21

Strength per Unit : 0.5mg / 100mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-11-21

Date Granted : 2021-04-06

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Knight Therapeutics Inc

ESTRADIOL HEMIHYDRATE, PROGESTERONE

ChemOutsourcing

Not Confirmed

Knight Therapeutics Inc

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-21

Date Granted : 2021-04-06

ESTRADIOL HEMIHYDRATE, PROGESTERONE

Brand Name : BIJUVA

Patent Number : 2856520

Filing Date : 2012-11-21

Strength per Unit : 1.0mg / 100mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-11-21

Date Granted : 2021-04-06

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Knight Therapeutics Inc

ESTRADIOL HEMIHYDRATE

ChemOutsourcing

Not Confirmed

Knight Therapeutics Inc

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-18

Date Granted : 2022-09-13

ESTRADIOL HEMIHYDRATE

Brand Name : IMVEXXY

Patent Number : 2876968

Filing Date : 2013-06-18

Strength per Unit : 4 mcg

Dosage Form : INSERT

Human Or VET : Human

Route of Administration : VAGINAL

Patent Expiration Date : 2033-06-18

Date Granted : 2022-09-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Knight Therapeutics Inc

ESTRADIOL HEMIHYDRATE

ChemOutsourcing

Not Confirmed

Knight Therapeutics Inc

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-18

Date Granted : 2022-09-13

ESTRADIOL HEMIHYDRATE

Brand Name : IMVEXXY

Patent Number : 2876968

Filing Date : 2013-06-18

Strength per Unit : 10 mcg

Dosage Form : INSERT

Human Or VET : Human

Route of Administration : VAGINAL

Patent Expiration Date : 2033-06-18

Date Granted : 2022-09-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!